Source
(June 25, 1938, ch. 675, § 505B, as added Pub. L. 108–155, § 2(a), Dec. 3, 2003, 117 Stat. 1936.)
Effective Date
Pub. L. 108–155, § 4, Dec. 3, 2003,
117 Stat. 1942, provided that:
“(a) In General.—Subject to subsection (b), this Act [enacting this section, amending sections
355,
355a, and
355b of this title and sections
262 and
284m of Title
42, The Public Health and Welfare, enacting provisions set out as a note under section
301 of this title, and amending provisions set out as notes under section
355a of this title and section
284m of Title
42] and the amendments made by this Act take effect on the date of enactment of this Act [Dec. 3, 2003].
“(b) Applicability to New Drugs and Biological Products.—
“(1) In general.—Subsection (a) of section
505B of the Federal Food, Drug, and Cosmetic Act [
21 U.S.C.
355c
(a)] (as added by section
2) shall apply to an application described in paragraph (1) of that subsection submitted to the Secretary of Health and Human Services on or after April 1, 1999.
“(2) Waivers and deferrals.—
“(A) Waiver or deferral granted.—If, with respect to an application submitted to the Secretary of Health and Human Services between April 1, 1999, and the date of enactment of this Act [Dec. 3, 2003], a waiver or deferral of pediatric assessments was granted under regulations of the Secretary then in effect, the waiver or deferral shall be a waiver or deferral under subsection (a) of section
505B of the Federal Food, Drug, and Cosmetic Act [
21 U.S.C.
355c
(a)], except that any date specified in such a deferral shall be extended by the number of days that is equal to the number of days between October 17, 2002, and the date of enactment of this Act.
“(B) Waiver and deferral not granted.—If, with respect to an application submitted to the Secretary of Health and Human Services between April 1, 1999, and the date of enactment of this Act [Dec. 3, 2003], neither a waiver nor deferral of pediatric assessments was granted under regulations of the Secretary then in effect, the person that submitted the application shall be required to submit assessments under subsection (a)(2) of section
505B of the Federal Food, Drug, and Cosmetic Act [
21 U.S.C.
355c
(a)(2)] on the date that is the later of—
“(i) the date that is 1 year after the date of enactment of this Act; or
“(ii) such date as the Secretary may specify under subsection (a)(3) of that section;
unless the Secretary grants a waiver under subsection (a)(4) of that section.
“(c) No Limitation of Authority.—Neither the lack of guidance or regulations to implement this Act or the amendments made by this Act nor the pendency of the process for issuing guidance or regulations shall limit the authority of the Secretary of Health and Human Services under, or defer any requirement under, this Act or those amendments.”